Research Article

Assessment of School Readiness in Chronic Cholestatic Liver Disease: A Pilot Study Examining Children with and without Liver Transplantation

Table 1

Demographic data.

LT NL
(%) (%)

Gender
 Female8 (61)4 (80)
Age at testing4.45 (3.03–6.97)4.07 (3.47–6.26)
Median, range [years]
Race
 White6 (46)2 (40)
 Black1 (7)
 Asian3 (23)3 (60)
 Others/not known3 (23)
Diagnosis
 Biliary Atresia13 (100)4 (80)
 Alpha 1 antitrypsin1 (20)
Mean body mass index at time of testing (range)16.7 (14.4–20.8)16.58 (15.3–17.3)
Attending school/daycare 11 (85)3 (60)
Maternal education
 High school graduate5 (38)1 (20)
 Postsecondary4 (30)4 (80)
 Postgraduate2 (15)0
 Not available2 (15)
Annual family income
 Under $50,0002 (15)3 (60)
 $50,001–$80,0001 (7)2 (40)
 Over $80,0017 (54)0
 Not available3 (23)
Type of immunosuppression
 Tacrolimus11 (85%)
 Sirolimus2 (15%)
# of rehabilitation service visits
 1–38 (62%)
 4–72 (15%)
 >71 (7)
Age at transplant
 <12 months7 (54%)
 12–23 months6 (46%)
Type of transplant
 Whole1 (8%)
 Reduced1 (8%)
 Split2 (15%)
 Live donor9 (69%)
Mean bilirubin at transplant (micromole/L) (range)45.5 (0–131)
Mean total days in hospital, before transplant (range)48.7 (0–172)
Mean total days in hospital, after transplant (range)65.3 (15–223)
Mean total days in hospital (range)114 (0–223)16.75 (5–25)
At time of transplantAt time of testing
Mean weight (kg) (range)8.17 (4.78–13.93)16.18 (14.7–17.6)
Mean INR (range)1.4 (1–1.9)0.94 (0.9–1)
Mean albumin levels (g/L) (range)29 (22–36)44.6 (37–49)
Medications (number of patients)
URSO80% (4)
Septra80% (4)